Release Date: 24/07/13 13:59 Summary: Response to ASX Price Query Letter Price Sensitive: Yes Download Document 95.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%